Quantitative analysis of PET data requires a metabolitecorrected arterial input function (AIF) for estimation of distribution volume and related outcome measures. Collecting arterial blood samples adds risk, cost, and patient discomfort to PET studies. Minimally invasive AIF estimation is possible with simultaneous estimation (SIME), but one arterial blood sample is necessary to be used as an anchor value to ensure identifiability of each individuals AIF. For [ 11 C]DASB, a widely used serotonin transporter PET tracer, this blood sample is optimally taken 50 minutes after injection. We present here an approach for replacing such a single time-point anchor with a predicted value using brain imaging and electronic health record (EHR) data. Average bootstrap R 2 > 0.8 in training data suggest that up to 80% of the variance in [
INTRODUCTION
Positron emission tomography (PET) is used for quantifying the distribution of receptors and proteins in the brain and the body. Quantitative analysis of PET data requires both the metabolite-corrected arterial input function (AIF) and the tissue time activity curves (TACs) derived from the image data for estimation of distribution volume and related outcome measures [1] . The AIF is measured in order to account for inter-and intra-individual variance in tracer availability due to metabolism and clearance. Blood samples are collected from the radial artery during the PET scan to calculate the AIF. This procedure adds risk, cost and patient discomfort to the demands of PET studies.
Significant progress has been made over the years towards less invasive PET analysis. Reference tissue methods have been developed but require the existence of a reference region devoid of specific binding, which for [11C]DASB does not exist [2] . Image-derived input function (IDIF) approaches recover the AIF by extracting signal from the carotid artery or cranial blood pools. IDIF methods are prone to partial volume effects and still require blood samples to scale the signal [3] . Minimally invasive AIF estimation is possible with simultaneous estimation (SIME) [4] , but at least one blood sample still needed as an individual anchor value for identifiability. For [11C]DASB, this sample is optimally taken 50 minutes after injection [4] . This single blood sample adds risk and discomfort to the study and leaves the PET analysis reliant on the accuracy of a single data point.
Population pharmacokinetics and pharmacodynamics (PPKD) is a field centered around predicting metabolite corrected blood levels of pharmaceutical compounds at various time points after injection/ingestion. This is done by aggregating blood data from multiple studies and searching for covariates (e.g. age, lab tests, etc.) that explain the variability in drug blood concentration [5] . As a PET tracer is also a pharmaceutical compound, similar covariate screening approaches may be effective for [
11 C]DASB. PET imaging data may add additional information on tracer blood concentrations. Previous work suggests that combining supplementary information (e.g. weight, dose, etc.) with signal from cranial blood vessel improve prediction of the AIF [6] . However, this technique was developed with the [
18 F]FDG tracer, for which the AIF does not require metabolite correction, and thus the imaging data is highly correlated with the AIF. It is not clear if such an approach could translate to [
11 C]DASB where the AIF profile is highly dependent on the rate of tracer metabolism and clearance.
In this study, we expand on [4, 5, 6] 2012 . EHR data collected prior to the PET scan date and included demographics (e.g., weight, gender, etc.), blood workup (e.g., chemistry, hematology, thyroid panel) and urinalysis (e.g., pH). PET data included sum 50-90 minute gray matter cerebellar activity (CER), injected dose (ID), injected mass, tracer specific activity, and the metabolite-corrected AIF. Heart rate (HR) and blood pressure (BP) were obtained within hours before and after the PET scan. Only subjects that had weight, height and AIF data available were included in the study. The final data set consisted of 95 subjects and 92 initial variables. Descriptive statistics for the subjects are shown in Table 1 .
Heart rate and blood pressure
HR was measured manually via radial pulse rate before (HRpre) and after (HRpost) the PET scan. Systolic (SBP) and diastolic (DBP) BP measurements were obtained with a sphygmomanometer before (SBPpre, DBPpre) and after (SBPpost, DBPpost) the scan. HR and BP were manually transcribed from handwritten notes left on the PET protocol form by clinical technicians. Missing or illegible measurements were marked as NaN. Vitals were not assessed at consistent times, ranging between 9 and 1 hours for prescan and between 2 and 8 hours for post-scan measurements. Therefore, variables that represent the closest and average (avg) vitals were also calculated: HRclosest, SBPclosest, DBPclosest, HRavg, SBPavg, DBPavg. The following derived variables were also calculated based on HR and BP: mean arterial pressure (MAP), estimated cardiac output (eCO) and pulse pressure (PP), using Eq. 1-3. Summary statistics for vitals are shown in Table 2 .
Derived variables
Body-mass index (BMI) and surface area (BSA), estimated total blood volume (eTBV), estimated total plasma volume (eTPV), and estimated resting metabolic rate (eRMR) were 
The estimated glomerular filtration rate (eGFR) was calculated from the blood creatine level (Crt) as eRM R = 4.5W + 15.9H − 5Age + 5, male 4.5W + 15.9H − 5Age − 161, f emale (10)
Other calculated variables include osmolarity gap, albumin corrected calcium, blood viscosity, anion gap, BUN Creatine ratio, and plasma osmolarity using standard clinical formulas. Two additional variants of Eq. (9) were calculated using BUN and Albumin (GFR5, GF R5 BSA ).
Variable selection
The combination of EHR, PET, demographics, vitals and derived variables amounted to 92 initial predictors, as shown in Table 3 . Note that Total Plasma (TP) is the total radioactivity count in each blood sample taken at time t, where the AIF (t) = P arentF raction(t) × T P (t). For [
11 C]DASB, the response variable is the SIME 50 minute anchor (SA50), or SA50 = AIF (t = 50min). We took a multi-stage approach to screening variables that may be useful in predicting SA50. First, correlation with SA50 was examined, and variables retained if R 2 > 0. 
Statistical Analysis
Our final feature set consisted of 56 features (10 individual, 31 ID/variable ratios, and 15 interaction terms) that made it through one of the three feature screening stages. Predictors used for model development are shown in randomly drawn samples with replacement from the training data and evaluating on the entire training data. Models with the highest average R 2 in each category were applied to the training and test data.
RESULTS
Results for top models in terms of average R 2 with and without TP are shown in Table 5 . All the models yielded R 2 > 0.7. Increasing the number of variables from three to six yielded an R 2 gain of 0.105 and 0.111 with and without TP, respectively. With TP, variables in common were: CER and HR. Other variables present were: BP, eosin, ID, BSA, SpecificActivity and pH. For models without TP, variables in common were: CER, BP, HR, ID, eosin. Other variables present included: Weight, eTBV, and eRMR. It appears that to increase R 2 by 0.1 information about ID and body size is useful. Including TP in model improved R 2 by only 0.015 and 0.009 for the three and six variable model, respectively.
The top six-variable models with and without TP were applied to training and test data. Plots of predicted vs. measured anchor points are show in Figure 1 . Predictions for some points could not be computed due to missing data. With TP in the model, there is a more uniform scattering of points around the identity line and better predictions for the test data. When TP is not included, one test point appears as an outlier possibly due to the fact that TP is very accurately measured via blood sampling on the same day of the PET scan, while all other variables were measured hours to weeks prior. 
CONCLUSIONS
Models for predicting the SIME anchor for [ 11 C]DASB were developed using machine learning techniques. Results suggest that >80% of the variance in [
11 C]DASB metabolism may be explained by variability in HR, BP, ID, body size, and cerebellar gray matter uptake. This is encouraging because this was a retrospective study using data acquired sometimes anywhere from hours (i.e. HR, BP) to weeks (i.e. eosin, pH) from the PET scan date. Furthermore, HR, which appears as an important variable in all the models, was measured via manual radial pulse rate. Weight, a measure on which many other important predictors were based (i.e. eTBV, eRMR, CO) was measured up-to months before the scan. Finally, an extensive evaluation of outliers was not done. Despite these drawbacks, the performance of the models was encouraging and suggests that better predictions of the [
11 C]DASB anchor may be achieved with careful data collection in a prospective study. It is important to recognize the models presented here are the top models in each category in terms of R 2 . Many other models with comparable R 2 are not shown due to space constraints. Evaluation of TP variable, advanced machine-learning techniques, more extensive crossvalidation, out-of-sample performance evaluation, and outlier removal is the subject of future work.
